Original-Research: IGEA Pharma N.V. - von GBC AG Einstufung von GBC AG zu IGEA Pharma N.V. Unternehmen: IGEA Pharma N.V. ISIN: NL0012768675 Anlass der Studie: Research Report (Initial Coverage)
EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word(s): Agreement/Research Update IGEA Pharma N.V.: GBC AG TO START EQUITY COVERAGE OF IGEA PHARMA 04-Oct-2021 / 23:55 CET/CEST Release of an ad hoc announcement
IGEA Pharma N V : GBC AG TO START EQUITY COVERAGE OF IGEA PHARMA pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
EQS Group-Ad-hoc: IGEA Pharma N.V. / Key word: Half Year Results/Half Year Results IGEA Pharma N.V.: IGEA DISCLOSES ITS HALF-2021 FINANCIALS 30-Sep-2021 / 23:56 CET/CEST Release of an ad hoc. | October 1, 2021
EQS-Adhoc: IGEA Pharma N V : IGEA DISCLOSES ITS HALF-2021 FINANCIALS finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.